Dr. Colm Henry:

We work quite closely with other European countries. For example, we have put in place a Benelux agreement on access to medication with Holland, Belgium and Luxembourg. It has not led to the approval of a cancer drug but may in time when we have common negotiation and outcomes.

We work with other European countries on surveying likely new candidate screening programmes and participating in research to see whether they will be effective. I refer, for example, to prostate and lung cancers, which I think were mentioned in an earlier hearing.

As regards healthcare intelligence, I do not know whether Dr. McCarthy wants to comment on any work we do with other European countries.